Medicinal Genomics
Juliana Sillva is an Associate Scientist at Medicinal Genomics, having started in January 2023, and previously completed multiple internships in the biotechnology field. These internships include roles at CuriRx, Inc. from May 2022 to December 2022 and at Medicinal Genomics from January 2021 to May 2022. Juliana also interned at Sage Science, Inc. during two separate periods, from December 2019 to January 2020 and from May 2020 to August 2020. Juliana earned a Bachelor's degree in Biology/Biotechnology from Endicott College, where attendance spanned from 2019 to 2023, following a High School Diploma from Bishop Fenwick High School in Peabody, MA, obtained in 2019.
This person is not in the org chart
This person is not in any offices
Medicinal Genomics
Medicinal Genomics is pioneering the genomics of medical cannabis and hemp. In 2011, Medicinal Genomics made worldwide headlines for being the first group to decode the Cannabis Genome. An increasing amount of scientific evidence supports the theory that cannabinoid compounds may have numerous medical benefits. Medicinal Genomics has the largestDNA sequence database of the cannabis plant and is well-positioned to design fingerprinting assays for strain genotyping and sequencing services for strain development. In 2011, Medicinal Genomics was acquired by Courtagen Life Sciences, Inc.